1. Home
  2. STVN vs LPX Comparison

STVN vs LPX Comparison

Compare STVN & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • LPX
  • Stock Information
  • Founded
  • STVN 1949
  • LPX 1973
  • Country
  • STVN Italy
  • LPX United States
  • Employees
  • STVN N/A
  • LPX N/A
  • Industry
  • STVN Containers/Packaging
  • LPX Forest Products
  • Sector
  • STVN Consumer Discretionary
  • LPX Basic Materials
  • Exchange
  • STVN Nasdaq
  • LPX Nasdaq
  • Market Cap
  • STVN 6.6B
  • LPX 6.2B
  • IPO Year
  • STVN 2021
  • LPX N/A
  • Fundamental
  • Price
  • STVN $24.59
  • LPX $91.77
  • Analyst Decision
  • STVN Buy
  • LPX Buy
  • Analyst Count
  • STVN 6
  • LPX 8
  • Target Price
  • STVN $25.08
  • LPX $107.38
  • AVG Volume (30 Days)
  • STVN 337.6K
  • LPX 975.6K
  • Earning Date
  • STVN 08-05-2025
  • LPX 08-06-2025
  • Dividend Yield
  • STVN 0.26%
  • LPX 1.22%
  • EPS Growth
  • STVN N/A
  • LPX 56.47
  • EPS
  • STVN 0.50
  • LPX 5.71
  • Revenue
  • STVN $1,215,562,040.00
  • LPX $2,941,000,000.00
  • Revenue This Year
  • STVN $8.69
  • LPX N/A
  • Revenue Next Year
  • STVN $10.67
  • LPX $7.00
  • P/E Ratio
  • STVN $49.56
  • LPX $16.07
  • Revenue Growth
  • STVN 3.81
  • LPX 8.09
  • 52 Week Low
  • STVN $17.12
  • LPX $78.82
  • 52 Week High
  • STVN $25.88
  • LPX $122.87
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.81
  • LPX 57.70
  • Support Level
  • STVN $24.06
  • LPX $85.21
  • Resistance Level
  • STVN $25.36
  • LPX $92.59
  • Average True Range (ATR)
  • STVN 1.10
  • LPX 2.29
  • MACD
  • STVN 0.01
  • LPX 0.53
  • Stochastic Oscillator
  • STVN 67.06
  • LPX 94.01

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: